60 related articles for article (PubMed ID: 1129035)
1. [Chemotherapeutic combinations of mutually potentiating drugs. 2-Application to the treatment of bronchial cancers].
Pouillart P; Schwarzenberg L; Amiel JL; Mathé G; Huguenin P; Morin P; Baron A; Laparre Ch; Parrot R
Nouv Presse Med; 1975 Mar; 4(10):717-9. PubMed ID: 1129035
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapeutic combinations of mutually potentiating drugs. 3-Application to primary tumors of the central nervous system].
Pouillart P; Schwarzenberg L; Amiel JL; Mathé G; Huguenin P; Morin P; Baron A; Laparre Ch; Parrot R
Nouv Presse Med; 1975 Mar; 4(10):721-4. PubMed ID: 165461
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapeutic combinations of mutually potentializing drugs. 1-Application to the treatment of breast cancers].
Pouillart P; Schwarzenberg L; Amiel JL; Mathé G; Huguenin P; Morin P; Baron A; Laparre Ch; Parrot R
Nouv Presse Med; 1975 Mar; 4(10):713-6. PubMed ID: 1129034
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
6. Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy.
Kübler AC; de Carpentier J; Hopper C; Leonard AG; Putnam G
Int J Oral Maxillofac Surg; 2001 Dec; 30(6):504-9. PubMed ID: 11829232
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
8. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer.
Georgoulias V; Misset JL; Ribaud P; Machover D; De Vassal F; Dorval T; Musset M; Schwarzenberg L; Reizenstein P; Mathe G; Gaget H
Anticancer Res; 1983; 3(2):107-10. PubMed ID: 6189445
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial. The French Associations for Surgical Research.
Levard H; Pouliquen X; Hay JM; Fingerhut A; Langlois-Zantain O; Huguier M; Lozach P; Testart J
Eur J Surg; 1998 Nov; 164(11):849-57. PubMed ID: 9845131
[TBL] [Abstract][Full Text] [Related]
12. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma.
Maoleekoonpairoj S; Phromratanapongse P; Puttanuparp S
J Med Assoc Thai; 1997 Dec; 80(12):778-84. PubMed ID: 9470331
[TBL] [Abstract][Full Text] [Related]
13. The role of chemotherapy in the treatment of lung cancer.
Selawry OS
Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
[No Abstract] [Full Text] [Related]
14. [New chemotherapeutic method for the treatment of tracheal and bronchial cancers--nebulization chemotherapy].
Tatsumura T; Yamamoto K; Murakami A; Tsuda M; Sugiyama S
Gan No Rinsho; 1983 Jun; 29(7):765-70. PubMed ID: 6308308
[TBL] [Abstract][Full Text] [Related]
15. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.
Vogl SE; Qazi R; Berenzweig M
Cancer Treat Rep; 1980; 64(10-11):1143-5. PubMed ID: 7459902
[TBL] [Abstract][Full Text] [Related]
18. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
19. Combination CCNU and bleomycin therapy for squamous cell carcinoma.
Lindell TD; Moseley HS; Fletcher WS
Am Surg; 1974 May; 40(5):281-9. PubMed ID: 4132376
[No Abstract] [Full Text] [Related]
20. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
